Aclarion Stock (NASDAQ:ACON)

Revenue Ownership Financials Chart

Previous Close

$0.18

52W Range

$0.18 - $9.90

50D Avg

$0.27

200D Avg

$1.24

Market Cap

$1.66M

Avg Vol (3M)

$496.41K

Beta

0.44

Div Yield

-

ACON Company Profile

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

4

IPO Date

Apr 22, 2022

Website

ACON Performance

ACON Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	$75.40K	$60.44K	$60.29K
Operating Income	$-4.88M	$-6.10M	$-2.95M
Net Income	$-4.91M	$-9.11M	$-3.53M
EBITDA	$-4.88M	$-5.90M	$-4.66M
Basic EPS	$-8.82	$-1.49	$-0.49
Diluted EPS	$-8.82	$-1.49	$-0.49

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison

Ticker	Company
FORA	Forian Inc.
ETAO	ETAO International Co., Ltd.
NRC	National Research Corporation
HCTI	Healthcare Triangle, Inc.
AKLI	Akili, Inc.
MGRX	Mangoceuticals, Inc.
HSTM	HealthStream, Inc.
AUGX	Augmedix, Inc.
EUDA	EUDA Health Holdings Limited